人工器官和醫用仿生學市場：按類型、最終用戶和地區分類

Artificial Vital Organs And Medical Bionics Market, By Type, By End User, and by Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，人造器官和醫用仿生學市場規模將達到681.9億美元，2033年將達到1,354.4億美元。預計從2026年到2033年，該市場將以10.3%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	681.9億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	10.30%	預計金額（2033 年）	1354.4億美元

人工器官是指人工製造的器官裝置或組織，用於替代天然器官，複製或增強特定功能，並透過植入或整合到人體並與活體組織相互作用，使患者盡快恢復正常生活。被替代的功能不一定與生命維持有關，但通常確實如此。用於置換術的人工骨骼和關節也可被視為人工器官。新產品的不斷推出、研發活動的活性化以及大型企業的策略將推動人工器官領域的成長。此外，新產品的獲批和政府的持續支持預計也將促進該領域的成長。由於嚴重感染疾病、心血管疾病和創傷導致的器官衰竭發生率不斷上升，器官移植手術的數量也增加。

市場動態

醫療設備業的領導者正致力於研發用於各種外科手術的先進儀器、設備和系統。因此，這些先進產品的推出預計將在預測期內推動人工器官和醫用仿生學市場的成長。例如，2023年2月25日，全球首款也是目前唯一一款獲得美國食品藥物管理局（FDA）已通過核准的商用全人工心臟製造商SynCardia Systems LLC宣布，FDA已批准其「Freedom攜帶式驅動程式」的關鍵軟體升級。此次升級在正常血壓條件下，將50cc和70cc兩種型號心臟的心摶出量和充盈量測量精度提高了5%，從而消除了現有設備中出現的許多意外警報。此外，此次升級也使設備即使在極端情況下（例如極度高血容量和高血壓）也能顯示準確的測量結果。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）對全球人工器官和醫療仿生市場的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球人工器官和醫用仿生市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球人造器官和醫用仿生學市場中使用的各種策略矩陣來促進決策。

公司簡介
- SynCardia Systems, LLC
- Peters Surgical SASU
- BiVACOR
- CARMAT
- Cleveland Heart
- Jarvik Heart
- MyLVAD
- Cirtec Medical Systems
- Thoratec Corporation
- Abbott Diabetes Care, Inc.
- Abiomed, Inc.
- Asahi Kasei Medical Co., Ltd.
- Cyberonics, Inc.
- Edwards Lifesciences Corporation
- Ekso Bionics Holdings, Inc.
- F. Hoffmann-La Roche Ltd.
- Fresenius Medical Care AG & Co. KGaA
- Gambro AB（Baxter International, Inc.）
- iWalk, Inc..

第8章

參考
分析方法

簡介目錄

Product Code: CMI3896

Artificial Vital Organs And Medical Bionics Market is estimated to be valued at USD 68.19 Bn in 2026 and is expected to reach USD 135.44 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 68.19 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.30%	2033 Value Projection:	USD 135.44 Bn

An artificial organ is a man-made organ device or tissue that is implanted or integrated into a human interacting with living tissue to replace a natural organ, duplicate or augment a specific function or functions, and allow the patient to resume normal life as soon as possible. The replaced function is not required to be related to life support, but it is frequently. Replacement bones and joints, such as those used in hip replacements, could be thought of as artificial organs. Increased product launches, increased research & developement activities, and key market players strategies will drive the artificial organs segment's growth. Furthermore, new product approvals and ongoing government support are expected to fuel the segment's growth. The increasing prevalence of organ failure due to severe infections, cardiovascular disease, and trauma raises the number of organ transplant surgeries.

Market Dynamics

The key players in the medical devices industry are focusing on the development of technologically advanced equipment, instruments, and systems for various surgical procedures. Thus, introduction of such advanced products in the market is expected to drive growth of the artificial vital organs and medical bionics market over the forecast period. For instance, On February 25, 2023, SynCardia Systems LLC, a manufactures, sells, and markets the world's first and only US FDA approved and commercially available Total Artificial Heart mechanical heart, announced that the U.S. Food and Drug Administration (FDA) has approved significant software upgrades to the Freedom Portable Driver. This upgrade improve the accuracy of the cardiac output and fill volume measurements to 5% at normotensive conditions. on both the 50cc and 70cc hearts, and in so doing, eliminate a significant number of the unintended alarms that the current device has been experiencing. The upgrade also ensure that even in extreme cases of hypervolemia and hypertension, the device display correct measurements.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial vital organs and medical bionicss market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global artificial vital organs and medical bionics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial vital organs and medical bionicss market

Detailed Segmentation:

Global Artificial Vital Organs And Medical Bionics Market, By Type (Revenue, USD Bn, 2021 - 2033)
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
Artificial Vital Organs
Medical Bionics
Global Artificial Vital Organs And Medical Bionics Market, by End User (Revenue, USD Bn, 2021 - 2033)
Hospital
Clinics
Ambulatory Surgical Centers
Global Artificial Vital Organs And Medical Bionics Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
SynCardia Systems, LLC
BiVACOR
CARMAT
Cleveland Heart
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co.Ltd.
Cyberonics, Inc.
Edwards Lifesciences Corporation
Ekso Bionics Holdings, Inc.
F. Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
Gambro AB (Baxter International, Inc.)
iWalk, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Artificial Vital Organs And Medical Bionics Market, By Type, 2021-2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Artificial Vital Organs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
  - Artificial Heart
  - Artificial Kidney
  - Artificial Liver
  - Artificial Pancreas
  - Artificial Lungs
Medical Bionics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
  - Cochlear Implants
  - Vision Bionics
  - Exoskeletons
  - Bionic Limbs
  - Brain Bionics
  - Cardiac Bionics

5. Global Artificial Vital Organs And Medical Bionics Market, By End User, 2021-2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

6. Global Artificial Vital Organs And Medical Bionics Market, By Regions, 2021-2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, By Type, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021-2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Type, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021-2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021-2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Type, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021-2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Type, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021-2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021-2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- SynCardia Systems, LLC *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Peters Surgical SASU
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- BiVACOR
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CARMAT
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cleveland Heart
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Jarvik Heart
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- MyLVAD
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cirtec Medical Systems
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thoratec Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott Diabetes Care, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abiomed, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Asahi Kasei Medical Co., Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cyberonics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Edwards Lifesciences Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ekso Bionics Holdings, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- F. Hoffmann-La Roche Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Medical Care AG & Co. KGaA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gambro AB (Baxter International, Inc.)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- iWalk, Inc..
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies